世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bispecific Monoclonal Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5624
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、二重特異性モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・二重特異性モノクローナル抗体の市場動向
・企業の競争状況、市場シェア
・二重特異性モノクローナル抗体の種類別市場規模と予測2016-2027（フラグメントベース抗体、IgGベース抗体）
・二重特異性モノクローナル抗体の用途別市場規模と予測2016-2027（がん、血友病、その他非がん性疾患）
・二重特異性モノクローナル抗体の北米市場規模2016-2027（アメリカ、カナダ）
・二重特異性モノクローナル抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・二重特異性モノクローナル抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・二重特異性モノクローナル抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・二重特異性モノクローナル抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche (Chugai)、Amgen）
・結論

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.

Market Analysis and Insights: Global Bispecific Monoclonal Antibodies Market
The global Bispecific Monoclonal Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bispecific Monoclonal Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bispecific Monoclonal Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bispecific Monoclonal Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bispecific Monoclonal Antibodies market.

Global Bispecific Monoclonal Antibodies Scope and Market Size
Bispecific Monoclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies

Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche (Chugai)
Amgen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Monoclonal Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fragment-Based Antibodies
1.2.3 IgG-Based Antibodies
1.3 Market by Application
1.3.1 Global Bispecific Monoclonal Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bispecific Monoclonal Antibodies Market Perspective (2016-2027)
2.2 Bispecific Monoclonal Antibodies Growth Trends by Regions
2.2.1 Bispecific Monoclonal Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bispecific Monoclonal Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 Bispecific Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 Bispecific Monoclonal Antibodies Industry Dynamic
2.3.1 Bispecific Monoclonal Antibodies Market Trends
2.3.2 Bispecific Monoclonal Antibodies Market Drivers
2.3.3 Bispecific Monoclonal Antibodies Market Challenges
2.3.4 Bispecific Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bispecific Monoclonal Antibodies Players by Revenue
3.1.1 Global Top Bispecific Monoclonal Antibodies Players by Revenue (2016-2021)
3.1.2 Global Bispecific Monoclonal Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global Bispecific Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bispecific Monoclonal Antibodies Revenue
3.4 Global Bispecific Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global Bispecific Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Monoclonal Antibodies Revenue in 2020
3.5 Bispecific Monoclonal Antibodies Key Players Head office and Area Served
3.6 Key Players Bispecific Monoclonal Antibodies Product Solution and Service
3.7 Date of Enter into Bispecific Monoclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bispecific Monoclonal Antibodies Breakdown Data by Type
4.1 Global Bispecific Monoclonal Antibodies Historic Market Size by Type (2016-2021)
4.2 Global Bispecific Monoclonal Antibodies Forecasted Market Size by Type (2022-2027)

5 Bispecific Monoclonal Antibodies Breakdown Data by Application
5.1 Global Bispecific Monoclonal Antibodies Historic Market Size by Application (2016-2021)
5.2 Global Bispecific Monoclonal Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bispecific Monoclonal Antibodies Market Size (2016-2027)
6.2 North America Bispecific Monoclonal Antibodies Market Size by Type
6.2.1 North America Bispecific Monoclonal Antibodies Market Size by Type (2016-2021)
6.2.2 North America Bispecific Monoclonal Antibodies Market Size by Type (2022-2027)
6.2.3 North America Bispecific Monoclonal Antibodies Market Size by Type (2016-2027)
6.3 North America Bispecific Monoclonal Antibodies Market Size by Application
6.3.1 North America Bispecific Monoclonal Antibodies Market Size by Application (2016-2021)
6.3.2 North America Bispecific Monoclonal Antibodies Market Size by Application (2022-2027)
6.3.3 North America Bispecific Monoclonal Antibodies Market Size by Application (2016-2027)
6.4 North America Bispecific Monoclonal Antibodies Market Size by Country
6.4.1 North America Bispecific Monoclonal Antibodies Market Size by Country (2016-2021)
6.4.2 North America Bispecific Monoclonal Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bispecific Monoclonal Antibodies Market Size (2016-2027)
7.2 Europe Bispecific Monoclonal Antibodies Market Size by Type
7.2.1 Europe Bispecific Monoclonal Antibodies Market Size by Type (2016-2021)
7.2.2 Europe Bispecific Monoclonal Antibodies Market Size by Type (2022-2027)
7.2.3 Europe Bispecific Monoclonal Antibodies Market Size by Type (2016-2027)
7.3 Europe Bispecific Monoclonal Antibodies Market Size by Application
7.3.1 Europe Bispecific Monoclonal Antibodies Market Size by Application (2016-2021)
7.3.2 Europe Bispecific Monoclonal Antibodies Market Size by Application (2022-2027)
7.3.3 Europe Bispecific Monoclonal Antibodies Market Size by Application (2016-2027)
7.4 Europe Bispecific Monoclonal Antibodies Market Size by Country
7.4.1 Europe Bispecific Monoclonal Antibodies Market Size by Country (2016-2021)
7.4.2 Europe Bispecific Monoclonal Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bispecific Monoclonal Antibodies Market Size (2016-2027)
8.2 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type
8.2.1 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application
8.3.1 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Region
8.4.1 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bispecific Monoclonal Antibodies Market Size (2016-2027)
9.2 Latin America Bispecific Monoclonal Antibodies Market Size by Type
9.2.1 Latin America Bispecific Monoclonal Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America Bispecific Monoclonal Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America Bispecific Monoclonal Antibodies Market Size by Type (2016-2027)
9.3 Latin America Bispecific Monoclonal Antibodies Market Size by Application
9.3.1 Latin America Bispecific Monoclonal Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America Bispecific Monoclonal Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America Bispecific Monoclonal Antibodies Market Size by Application (2016-2027)
9.4 Latin America Bispecific Monoclonal Antibodies Market Size by Country
9.4.1 Latin America Bispecific Monoclonal Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America Bispecific Monoclonal Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bispecific Monoclonal Antibodies Market Size (2016-2027)
10.2 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type
10.2.1 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application
10.3.1 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Country
10.4.1 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche (Chugai)
11.1.1 Roche (Chugai) Company Details
11.1.2 Roche (Chugai) Business Overview
11.1.3 Roche (Chugai) Bispecific Monoclonal Antibodies Introduction
11.1.4 Roche (Chugai) Revenue in Bispecific Monoclonal Antibodies Business (2016-2021)
11.1.5 Roche (Chugai) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Bispecific Monoclonal Antibodies Introduction
11.2.4 Amgen Revenue in Bispecific Monoclonal Antibodies Business (2016-2021)
11.2.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bispecific Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fragment-Based Antibodies
Table 3. Key Players of IgG-Based Antibodies
Table 4. Global Bispecific Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bispecific Monoclonal Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bispecific Monoclonal Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bispecific Monoclonal Antibodies Market Share by Regions (2016-2021)
Table 8. Global Bispecific Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bispecific Monoclonal Antibodies Market Share by Regions (2022-2027)
Table 10. Bispecific Monoclonal Antibodies Market Trends
Table 11. Bispecific Monoclonal Antibodies Market Drivers
Table 12. Bispecific Monoclonal Antibodies Market Challenges
Table 13. Bispecific Monoclonal Antibodies Market Restraints
Table 14. Global Bispecific Monoclonal Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bispecific Monoclonal Antibodies Market Share by Players (2016-2021)
Table 16. Global Top Bispecific Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Monoclonal Antibodies as of 2020)
Table 17. Ranking of Global Top Bispecific Monoclonal Antibodies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bispecific Monoclonal Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bispecific Monoclonal Antibodies Product Solution and Service
Table 21. Date of Enter into Bispecific Monoclonal Antibodies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bispecific Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Table 25. Global Bispecific Monoclonal Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bispecific Monoclonal Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bispecific Monoclonal Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bispecific Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
Table 29. Global Bispecific Monoclonal Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bispecific Monoclonal Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bispecific Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bispecific Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bispecific Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bispecific Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bispecific Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bispecific Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bispecific Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bispecific Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bispecific Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bispecific Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bispecific Monoclonal Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bispecific Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bispecific Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bispecific Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bispecific Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bispecific Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche (Chugai) Company Details
Table 62. Roche (Chugai) Business Overview
Table 63. Roche (Chugai) Bispecific Monoclonal Antibodies Product
Table 64. Roche (Chugai) Revenue in Bispecific Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 65. Roche (Chugai) Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Bispecific Monoclonal Antibodies Product
Table 69. Amgen Revenue in Bispecific Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bispecific Monoclonal Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Fragment-Based Antibodies Features
Figure 3. IgG-Based Antibodies Features
Figure 4. Global Bispecific Monoclonal Antibodies Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Haemophilia Case Studies
Figure 7. Other Non-Cancer Diseases Case Studies
Figure 8. Bispecific Monoclonal Antibodies Report Years Considered
Figure 9. Global Bispecific Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bispecific Monoclonal Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bispecific Monoclonal Antibodies Market Share by Regions: 2020 VS 2027
Figure 12. Global Bispecific Monoclonal Antibodies Market Share by Regions (2022-2027)
Figure 13. Global Bispecific Monoclonal Antibodies Market Share by Players in 2020
Figure 14. Global Top Bispecific Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Monoclonal Antibodies as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bispecific Monoclonal Antibodies Revenue in 2020
Figure 16. Global Bispecific Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure 17. Global Bispecific Monoclonal Antibodies Revenue Market Share by Type (2022-2027)
Figure 18. North America Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bispecific Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 20. North America Bispecific Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 21. North America Bispecific Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 22. United States Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bispecific Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 26. Europe Bispecific Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 27. Europe Bispecific Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 28. Germany Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bispecific Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bispecific Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bispecific Monoclonal Antibodies Market Share by Region (2016-2027)
Figure 38. China Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bispecific Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 46. Latin America Bispecific Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 47. Latin America Bispecific Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 48. Mexico Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bispecific Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bispecific Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bispecific Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 54. Turkey Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bispecific Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche (Chugai) Revenue Growth Rate in Bispecific Monoclonal Antibodies Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Bispecific Monoclonal Antibodies Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2021-2027
QFJ1-4941 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、タンパク質＆抗体＆核酸デリバリー技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、...

世界のGMP生物製剤市場規模・現状・予測（2021年-2027年）

Global GMP Biologics Market Size, Status and Forecast 2021-2027
QFJ1-4268 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、GMP生物製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ポリクローナル抗体）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年）

Global Anti-DPH5 Antibody Produced In Rabbit Market Size, Status and Forecast 2021-2027
QFJ1-3827 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウサギ抽出抗DPH5抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ポリクローナル抗体）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界の抗核抗体検査市場規模・現状・予測（2021年-2027年）

Global Anti-Nuclear Antibody Test Market Size, Status and Forecast 2021-2027
QFJ1-3832 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、抗核抗体検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、間接蛍光抗体法、マルチプレックス試験）、用途別市場規模（全身性エリテマトーデス、シェーグレン症候群、関節リウマチ、強皮症、多発性...

世界の個別化がん医療市場規模・現状・予測（2021年-2027年）

Global Personalized Cancer Medicine Market Size, Status and Forecast 2021-2027
QFJ1-4689 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、個別化がん医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、個別化がんワクチン、その他）、用途別市場規模（乳がん、肺がん、慢性骨髄性白血病、大腸がん、その他のがん）、主要地域別市...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年） Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neur…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界の個別化がん医療市場規模・現状・予測（2021年-2027年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…
二重バレル抗体薬のグローバル市場調査 2019年 The global Double Barreled Antibodies Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Double Barreled Antibodies Drug volume and value at global level, regional level and company level. From a …